phosphorus has been researched along with quinidine in 4 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (quinidine) | Trials (quinidine) | Recent Studies (post-2010) (quinidine) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 6,608 | 387 | 594 |
| Protein | Taxonomy | phosphorus (IC50) | quinidine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 6.4 | |
| Cholinesterase | Homo sapiens (human) | 1.23 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 10 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.32 | |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 2.8 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.3532 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 7.3 | |
| Cholinesterase | Equus caballus (horse) | 7.37 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 6.4 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.7882 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 6.4 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 6.4 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.9 | |
| Potassium voltage-gated channel subfamily D member 2 | Rattus norvegicus (Norway rat) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathur, PP; Mokler, CM | 1 |
| GRISOLIA, S | 1 |
| ELLS, HA; FURMAN, RH; HOWARD, RP | 1 |
| GIULIANI, G | 1 |
4 other study(ies) available for phosphorus and quinidine
| Article | Year |
|---|---|
A comparative study of the effects of quinidine and a newer antiarrhythmic agent, disopyramide, on mammalian myocardial metabolism of glucose and oxidative phosphorylation.
Topics: Amides; Animals; Anti-Arrhythmia Agents; Butyrates; Dogs; Ethanolamines; Glucose; Myocardium; Oxidative Phosphorylation; Oxygen Consumption; Phosphorus; Propranolol; Quinidine; Rabbits; Rats; Sulfates | 1969 |
The potentiating effect of digitoxin and quinidine on dinitrophenol uncoupling of oxidative phosphorylation.
Topics: Digitalis; Digitalis Glycosides; Digitoxin; Dinitrophenols; Nitrophenols; Oxidation-Reduction; Oxidative Phosphorylation; Phosphorus; Plant Extracts; Quinidine | 1955 |
The effect of quinidine and quinine on nitrogen and electrolyte balance (protein anabolic effect) and on glucose utilization.
Topics: Anabolic Agents; Calcium; Calcium, Dietary; Chlorides; Glucose; Guanidines; Guanine; Nitrogen; Phosphorus; Potassium; Proteins; Quinidine; Quinine; Sodium; Sodium, Dietary; Water-Electrolyte Balance | 1963 |
[TREATMENT OF MYASTHENIA].
Topics: Adrenocorticotropic Hormone; Cyclopropanes; Epinephrine; Galantamine; Humans; Hypnotics and Sedatives; Isoflurophate; Morphine; Myasthenia Gravis; Neostigmine; Neuromuscular Nondepolarizing Agents; Nitrogen; Organophosphate Poisoning; Parasympathomimetics; Phosphorus; Poisons; Quinidine; Quinine; Surgical Procedures, Operative; Thymus Gland | 1964 |